You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,822,424


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,822,424 protect, and when does it expire?

Patent 8,822,424 protects ZEMDRI and is included in one NDA.

This patent has twenty-eight patent family members in twenty-one countries.

Summary for Patent: 8,822,424
Title:Antibacterial aminoglycoside analogs
Abstract: Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): ##STR00001## including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q.sub.1, Q.sub.2, Q.sub.3, R.sub.8 and R.sub.9 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Inventor(s): Aggen; James Bradley (Burlingame, CA), Goldblum; Adam Aaron (Berkeley, CA), Linsell; Martin Sheringham (San Mateo, CA), Dozzo; Paola (San Francisco, CA), Moser; Heinz Ernst (San Mateo, CA), Hildebrandt; Darin James (Cupertino, CA), Gliedt; Micah James (Sunnyvale, CA)
Assignee: Achaogen, Inc. (South San Francisco, CA)
Application Number:13/734,729
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,822,424
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,822,424: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for both the patent holder and potential infringers. This article will delve into the details of United States Patent 8,822,424, exploring its claims, scope, and the broader patent landscape it inhabits.

Patent Overview

United States Patent 8,822,424, hereafter referred to as the '424 patent, was granted to its inventors after a thorough examination process by the U.S. Patent and Trademark Office (USPTO)[2].

Patent Title and Abstract

The title and abstract of the patent provide the first glimpse into its subject matter. While the specific title and abstract of the '424 patent are not provided here, these sections typically outline the invention's purpose, key features, and the problems it solves.

Claims

The claims section is the most critical part of any patent, as it defines the scope of protection granted to the inventor. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to one or more independent claims.

Independent Claims

Independent claims in the '424 patent would outline the broadest scope of the invention. These claims are typically more general and set the foundation for the dependent claims.

Dependent Claims

Dependent claims narrow down the scope by adding specific limitations or features to the independent claims. They often provide additional details that further define the invention.

Scope Concepts and Claim Coverage

To understand the full scope of the '424 patent, it is essential to analyze the claims in the context of scope concepts. This involves categorizing the claims not just by their individual wording but also by the overarching concepts they cover. Tools like ClaimScape® software can help in generating interactive claim charts that make it easier to review patent coverage and identify gaps or opportunities[3].

Patent Landscape Analysis

Family Members and Continuations

The '424 patent may be part of a larger patent family, including continuations, continuations-in-part, or divisional applications. Understanding the relationships between these family members is crucial, as seen in cases like In re Cellect, where multiple patents within a family were analyzed for obviousness-type double patenting (ODP)[1].

Prior Art and Obviousness

The validity of the '424 patent claims can be challenged based on prior art and obviousness. The USPTO and courts consider whether the claimed invention is novel and non-obvious over existing prior art. Any findings of unpatentability over prior art or other patents within the same family can significantly impact the patent's validity.

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

The '424 patent may have been granted a Patent Term Adjustment (PTA) for USPTO delays during prosecution. However, it is important to note that PTA and Patent Term Extension (PTE) under 35 U.S.C. § 156 have different implications, as highlighted in cases like Novartis AG v. Ezra Ventures LLC[1].

Determining Inventorship

Correctly identifying the inventors is a legal requirement for patent applications. The '424 patent must list the "true and only" inventors who conceived the idea and reduced it to practice. Misidentification of inventors can lead to the patent being invalidated[5].

Conception and Reduction to Practice

Inventorship involves two key steps: conception of the idea and reduction of the idea to practice. Ensuring that all true inventors are named and that no one is incorrectly included is vital for the patent's enforceability.

Geographical and Sectoral Analysis

Patent data, including the '424 patent, can be analyzed geographically and by sector. This involves understanding the residence of the inventors and the economic sector of the patent owner. Such analyses can reveal trends and patterns in patenting activity, which can be useful for regional economic studies[4].

Claim Charts and Scope Concepts

Using tools like ClaimScape® software, the claims of the '424 patent can be categorized by scope concepts, making it easier to filter, search, and analyze large numbers of patent claims. This helps in identifying gaps in current coverage and highlighting future design opportunities[3].

High, Medium, and Low Value Claims

Claims can be valued based on their current and potential future importance to the company. High-value claims are crucial to the company's current operations, medium-value claims indicate potential future directions, and low-value claims may not be worth maintaining.

Updating and Maintaining Patent Coverage

As new patents are filed or as the company explores other avenues of development, the claim charts and scope concepts need to be updated. This ensures that the patent landscape remains accurately reflected and that any gaps or opportunities are promptly identified[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is essential for defining the scope of protection.
  • Scope Concepts: Categorizing claims by overarching scope concepts helps in comprehensive analysis and identification of gaps.
  • Patent Landscape: Analyzing the patent family and prior art is crucial for assessing validity.
  • Inventorship: Correct identification of inventors is vital for the patent's enforceability.
  • Geographical and Sectoral Analysis: Understanding the geographical and sectoral context provides insights into patenting trends.
  • Claim Charts and Updates: Regularly updating claim charts ensures accurate reflection of the patent landscape.

FAQs

Q: What is the importance of independent claims in a patent?

A: Independent claims define the broadest scope of the invention and set the foundation for dependent claims, which are more specific.

Q: How does the USPTO determine the validity of patent claims?

A: The USPTO considers whether the claimed invention is novel and non-obvious over existing prior art during the examination process.

Q: What are the consequences of incorrect inventorship in a patent application?

A: Incorrect inventorship can lead to the patent being invalidated, as it is a legal requirement to list the "true and only" inventors.

Q: How can ClaimScape® software help in patent analysis?

A: ClaimScape® software generates interactive claim charts that help in categorizing claims by scope concepts, identifying gaps, and highlighting future design opportunities.

Q: Why is it important to update claim charts over time?

A: Updating claim charts ensures that the patent landscape remains accurately reflected as new patents are filed or as the company explores other development avenues.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO) - USAGov.
  3. Patent Analytics - Schwegman Lundberg & Woessner, P.A.
  4. Invention, Knowledge Transfer, and Innovation - National Science Foundation, March 8, 2022.
  5. Determining Inventorship for US Patent Applications - Oregon State University.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,822,424

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cipla Usa ZEMDRI plazomicin sulfate SOLUTION;INTRAVENOUS 210303-001 Jun 25, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.